Go Back
Ally Bridge Group
Ally Bridge Group, based in Hong Kong, is a global healthcare-focused investment group founded in 2013. The venture fund invests in various stages from Seed to Series D in companies within the BioTech, Healthcare, Medical Device, and Pharmaceuticals sectors. With a portfolio including companies like Elligo Health Research and Imperative Care, Ally Bridge Group has made 67 investments and has seen 27 exits. The fund, led by Partner Alan Chen, is committed to venture and growth capital, buyout, and hedge fund investing. For more information, visit their website at www.ally-bridge.com.
About
About
About
Bio
Ally Bridge Group is a global healthcare-focused investment group committed to venture and growth capital, buyout, and hedge fund investing.
Location
Hong Kong
Stage
Seed, Series A, Series B, Series C, Series D
Partner name
Alan Chen
Bio
Ally Bridge Group is a global healthcare-focused investment group committed to venture and growth capital, buyout, and hedge fund investing.
Location
Hong Kong
Stage
Seed, Series A, Series B, Series C, Series D
Partner name
Alan Chen
Fund
Fund
Fund
Fund Focus
BioTech, Healthcare, Medical Device, Pharmaceuticals
Number of investments
67
Number of exits
27
Fund Type
Venture Fund
Portfolio Companies
Elligo Health Research, Imperative Care, CG Oncology, Alzheon
Ally Bridge Group
Ally Bridge Group, based in Hong Kong, is a global healthcare-focused investment group founded in 2013. The venture fund invests in various stages from Seed to Series D in companies within the BioTech, Healthcare, Medical Device, and Pharmaceuticals sectors. With a portfolio including companies like Elligo Health Research and Imperative Care, Ally Bridge Group has made 67 investments and has seen 27 exits. The fund, led by Partner Alan Chen, is committed to venture and growth capital, buyout, and hedge fund investing. For more information, visit their website at www.ally-bridge.com.
About
Bio
Ally Bridge Group is a global healthcare-focused investment group committed to venture and growth capital, buyout, and hedge fund investing.
Location
Hong Kong
Stage
Seed, Series A, Series B, Series C, Series D
Partner name
Alan Chen
Fund
Fund Focus
BioTech, Healthcare, Medical Device, Pharmaceuticals
Number of investments
67
Number of exits
27
Fund Type
Venture Fund
Portfolio Companies
Elligo Health Research, Imperative Care, CG Oncology, Alzheon